These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1315440)

  • 1. Pregnane steroid alphaxalone attenuates anxiogenic behavioral effects of corticotropin releasing factor and stress.
    Britton KT; McLeod S; Koob GF; Hauger R
    Pharmacol Biochem Behav; 1992 Feb; 41(2):399-403. PubMed ID: 1315440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alphaxalone, a steroid anesthetic, inhibits the startle-enhancing effects of corticotropin releasing factor, but not strychnine.
    Swerdlow NR; Britton KT
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):141-6. PubMed ID: 7862886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
    Britton KT; Akwa Y; Spina MG; Koob GF
    Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity.
    Heinrichs SC; Menzaghi F; Pich EM; Baldwin HA; Rassnick S; Britton KT; Koob GF
    Neuropsychopharmacology; 1994 Nov; 11(3):179-86. PubMed ID: 7865099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.
    Stenzel-Poore MP; Heinrichs SC; Rivest S; Koob GF; Vale WW
    J Neurosci; 1994 May; 14(5 Pt 1):2579-84. PubMed ID: 8182429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone.
    Britton KT; Lee G; Dana R; Risch SC; Koob GF
    Life Sci; 1986 Oct; 39(14):1281-6. PubMed ID: 3489874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic activity of steroid anesthetic alphaxalone.
    Britton KT; Page M; Baldwin H; Koob GF
    J Pharmacol Exp Ther; 1991 Jul; 258(1):124-9. PubMed ID: 1677035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine and behavioural responses to acute central CRF challenge are antagonized in the periphery and CNS, respectively, in C57BL/6 mice.
    Pryce CR; Siegl S; Mayer R; Rahmanzadeh G; McAllister KH
    Neuropharmacology; 2011; 60(2-3):318-27. PubMed ID: 20868699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of the steroid anaesthetic alphaxalone to inhibit CRF-induced ACTH secretion in rats in the fast feedback time domain.
    Hinz B; Hirschelmann R
    Pharmazie; 1996 Jun; 51(6):433-4. PubMed ID: 8767856
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.
    Britton KT; Lee G; Vale W; Rivier J; Koob GF
    Brain Res; 1986 Mar; 369(1-2):303-6. PubMed ID: 3008937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-helical-corticotropin-releasing hormone reverses anxiogenic effects of C-type natriuretic peptide in rats.
    Jahn H; Montkowski A; Knaudt K; Ströhle A; Kiefer F; Schick M; Wiedemann K
    Brain Res; 2001 Mar; 893(1-2):21-8. PubMed ID: 11222988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist.
    Heinrichs SC; De Souza EB; Schulteis G; Lapsansky JL; Grigoriadis DE
    Neuropsychopharmacology; 2002 Aug; 27(2):194-202. PubMed ID: 12093593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO; Plotsky PM; Vale WW
    Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of corticotropin-releasing hormone and pituitary-adrenocortical response during acute and repeated stress in the rat.
    Culman J; Kopin IJ; Saavedra JM
    Endocr Regul; 1991 Sep; 25(3):151-8. PubMed ID: 1662551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test.
    Britton KT; Morgan J; Rivier J; Vale W; Koob GF
    Psychopharmacology (Berl); 1985; 86(1-2):170-4. PubMed ID: 3927353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF.
    Britton DR; Varela M; Garcia A; Rosenthal M
    Life Sci; 1986 Jan; 38(3):211-6. PubMed ID: 3001465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress.
    Ono N; Bedran de Castro JC; McCann SM
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3528-31. PubMed ID: 2987931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor has an anxiogenic action in the social interaction test.
    Dunn AJ; File SE
    Horm Behav; 1987 Jun; 21(2):193-202. PubMed ID: 2886414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.